Inactive Instrument

Elan Corporation Ltd Stock NYSE

Stocks

End-of-day quote NYSE
- ^USD	-

14-03-19	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
13-12-17	Elan Corporation, plc : Ex-SAC manager Martoma fails to end part of insider case	RE

14-03-19	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
13-12-17	Elan Corporation, plc : Ex-SAC manager Martoma fails to end part of insider case	RE
13-12-07	Pfizer Inc. : Ex-SAC trader points to Cohen testimony in insider trading case	RE
13-11-18	Elan Corporation, plc : Elan wins shareholder approval to complete Perrigo sale	RE
13-11-17	Elan Corporation, plc : The prosecutors with SAC Capital in their crosshairs	RE
13-10-23	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE
13-09-24	Bank of America Corp : Insider trading trial of SAC's Martoma delayed to January	RE
13-09-24	Pfizer Inc. : Insider trading trial of SAC's Martoma delayed until January	RE
13-08-22	Elan Corporation, plc : New Martoma indictment describes second doctor as insider source	RE
13-08-07	Perrigo Company : Exclusive - TPG explores $3 billion sale of specialty drugmaker Aptalis	RE
13-08-07	Actavis Inc : Exclusive: TPG explores $3 billion sale of specialty drugmaker Aptalis	RE
13-07-30	Omnicom Group Inc. : July merger flurry signals gradual pickup in deals	RE
13-07-29	Forest Laboratories, Inc. : U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 billion	RE

13-12-13	Elan Corporation, plc : Perrigo Company and Elan Corporation Plc Receive Irish High Court Approval for Perrigo’s Proposed Acquisition of Elan	PU
13-11-18	Elan Corporation, plc : Elan Announces Shareholder Approval of its Acquisition by Perrigo Company	BU
13-10-24	Elan Corporation, plc : Elan Reports Third Quarter 2013 Financial Results	BU
13-10-10	Elan Corporation, plc : Elan Announces Webcast of Third Quarter 2013 Financial Results	BU
13-09-30	Elan Corporation, plc : Elan Announces Dates of Shareholder Meetings in Connection with Scheme of Arrangement	BU

24-10-30	Meta dépasse les attentes au troisième trimestre grâce aux "progrès" sur l'IA
19-02-10	Paris repart en guerre contre Airbnb, avec une assignation en justice
19-02-09	Paris repart en guerre contre Airbnb avec une assignation en justice
13-07-29	Les valeurs à suivre aujourd'hui à Wall Street
13-07-29	Le point sur les marchés à la mi-séance en Europe

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.09%	+5.26%	+4.44%	+26.03%	51.61B
REVOLUTION MEDICINES, INC.	-1.07%	+2.82%	+474.18%	+601.24%	44.89B
IQVIA HOLDINGS INC.	+1.47%	+9.79%	+40.15%	+21.21%	42.77B
BEONE MEDICINES AG	+1.44%	+7.77%	+19.27%	+90.94%	42.58B
CELLTRION, INC.	-0.93%	-4.33%	+17.87%	+51.96%	31.82B
MEDPACE HOLDINGS, INC.	+1.32%	+7.30%	+36.93%	+152.36%	17.33B
ASCENDIS PHARMA A/S	-0.60%	+1.93%	-	-	16.63B
EUROFINS SCIENTIFIC SE	+0.03%	+3.41%	+7.12%	+35.49%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	+5.41%	+91.01%	+46.93%	14.09B
Average	+0.45%	+4.43%	+86.37%	+128.27%	30.72B
Weighted average by Cap.	+0.49%	+4.72%	+102.57%	+148.52%